1. Home
  2. COEP vs CXAI Comparison

COEP vs CXAI Comparison

Compare COEP & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • CXAI
  • Stock Information
  • Founded
  • COEP 2017
  • CXAI N/A
  • Country
  • COEP United States
  • CXAI United States
  • Employees
  • COEP N/A
  • CXAI N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • CXAI EDP Services
  • Sector
  • COEP Health Care
  • CXAI Technology
  • Exchange
  • COEP Nasdaq
  • CXAI Nasdaq
  • Market Cap
  • COEP 32.4M
  • CXAI 33.9M
  • IPO Year
  • COEP N/A
  • CXAI N/A
  • Fundamental
  • Price
  • COEP $11.54
  • CXAI $1.61
  • Analyst Decision
  • COEP
  • CXAI
  • Analyst Count
  • COEP 0
  • CXAI 0
  • Target Price
  • COEP N/A
  • CXAI N/A
  • AVG Volume (30 Days)
  • COEP 136.7K
  • CXAI 922.5K
  • Earning Date
  • COEP 03-25-2025
  • CXAI 11-12-2024
  • Dividend Yield
  • COEP N/A
  • CXAI N/A
  • EPS Growth
  • COEP N/A
  • CXAI N/A
  • EPS
  • COEP N/A
  • CXAI N/A
  • Revenue
  • COEP N/A
  • CXAI $7,200,000.00
  • Revenue This Year
  • COEP N/A
  • CXAI $3.86
  • Revenue Next Year
  • COEP N/A
  • CXAI $100.00
  • P/E Ratio
  • COEP N/A
  • CXAI N/A
  • Revenue Growth
  • COEP N/A
  • CXAI N/A
  • 52 Week Low
  • COEP $2.31
  • CXAI $1.09
  • 52 Week High
  • COEP $13.70
  • CXAI $7.07
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.40
  • CXAI 46.28
  • Support Level
  • COEP $8.65
  • CXAI $1.42
  • Resistance Level
  • COEP $13.70
  • CXAI $1.63
  • Average True Range (ATR)
  • COEP 2.11
  • CXAI 0.13
  • MACD
  • COEP -0.24
  • CXAI -0.01
  • Stochastic Oscillator
  • COEP 61.22
  • CXAI 31.15

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About CXAI CXApp Inc.

CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.

Share on Social Networks: